ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 12c, Beats on Revenue

Go back to ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 12c, Beats on Revenue
(NASDAQ: SPRY) Delayed: 6.10 --0 (-0%)
Previous Close $6.10    52 Week High
Open $6.10    52 Week Low
Day High $6.10    P/E N/A 
Day Low $6.10    EPS
Volume 3,392